Xaira Therapeutics Appoints Dr. Ian McCaffery as SVP and Promotes Dr. Ci Chu to Chief Discovery Officer
Position
Senior Vice President
Company
Xaira Therapeutics
BrisbaneBiotechnologyArtificial IntelligenceTherapeuticsMachine LearningDescription
Xaira Therapeutics has appointed Dr. Ian McCaffery as Senior Vice President, Translational Science and Early Clinical Development and promoted Dr. Ci Chu to Chief Discovery Officer
Quick answer
Xaira Therapeutics Appoints Dr. Ian McCaffery as SVP and Promotes Dr. Ci Chu to Chief Discovery Officer (July 6, 2026). Xaira Therapeutics is based in Brisbane, California, United States.
- Who is the new Senior Vice President at Xaira Therapeutics?
- Xaira Therapeutics named Ian McCaffery Senior Vice President, announced July 6, 2026.
- What did Xaira Therapeutics announce on July 6, 2026?
- Xaira Therapeutics has appointed Dr. Ian McCaffery as Senior Vice President, Translational Science and Early Clinical Development and promoted Dr. Ci Chu to Chief Discovery Officer
- What does Xaira Therapeutics do?
- Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease.
- Where is Xaira Therapeutics based?
- Xaira Therapeutics is based in Brisbane, California, United States.
- Which similar companies made leadership changes around the same time?
- Change Agents Corporation. (June 4, 2026), DataMeds AI, Inc. (July 16, 2026), Hitachi (July 17, 2026) and Nabla (July 21, 2026) also announced leadership changes within 45 days of Xaira Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Avalon Appoints Sam Knipper as Chief Financial Officer (June 4, 2026)
- Wellgistics Health Appoints Brett Thompson as Chief Technology Officer (July 16, 2026)
- Hitachi Rail Appoints Frank Antonysamy as CEO of Clever Devices (July 17, 2026)
- Nabla Appoints Brian Manning as Chief Executive Officer (July 21, 2026)
- MOMENTUS BioPharma Consulting Group Appoints Ed Shifflett as Chief Growth Officer (July 23, 2026)
- Acurion Appoints Mike Hoerres as Chief Commercial Officer and David Schlessinger as Vice President of Product Development (June 17, 2026)
Who to call at Xaira Therapeutics, and when
A new leader at Xaira Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Xaira Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xaira Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xaira Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xaira Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Xaira Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.